Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Product comprising a heterotrimeric G protein signal transduction inhibitor associated with anti-hypertensive agent for therapeutic use in the treatment of arterial hypertension

Product comprising a heterotrimeric G protein signal transduction inhibitor associated with anti-hypertensive agent for therapeutic use in the treatment of arterial hypertension

US Patent 6846822 · Granted Jan 25, 2005

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Imidazolidine-2,4-dione derivatives and use thereof as a medicament2014
Imidazole derivatives, preparation and user thereof as medicine2012
Inhibitors of cdc phosphatases2011
4,7-dioxobenzothiazole-2-carboxamide derivatives, their preparation and their th2010
Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 ph2009
Benzothiazole-and benzoxazole-4, 7-dione derivatives and their use as dcd25 phos2007
Cdc25 phosphatase inhibitors2007
Product comprising an inhibitor of the transduction of heterotrimeric G protein 2006
Product comprising an inhibitor of the transduction of heterotrimeric G protein 2006
DNA polymerase inhibitors, mikanolide and dihydromikanolide2006
Product inhibiting transduction of G heterotrimeric protein signals combined wit2006
Use of cysteine derivatives for the preparation of a medicament intended to trea2006